General Information of Drug (ID: DM9ESPR)

Drug Name
A1-10436
Synonyms N-{[4-(2-tert-Butylphenyl)piperazin-1-yl]carbonyl}glycine; SCHEMBL630380; CHEMBL3644467; BAZIXHMBHKLDIK-UHFFFAOYSA-N; BDBM135826; US8853215, 6; A1-10436
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 319.4
Logarithm of the Partition Coefficient (xlogp) 2.4
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C17H25N3O3
IUPAC Name
2-[[4-(2-tert-butylphenyl)piperazine-1-carbonyl]amino]acetic acid
Canonical SMILES
CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)NCC(=O)O
InChI
InChI=1S/C17H25N3O3/c1-17(2,3)13-6-4-5-7-14(13)19-8-10-20(11-9-19)16(23)18-12-15(21)22/h4-7H,8-12H2,1-3H3,(H,18,23)(H,21,22)
InChIKey
BAZIXHMBHKLDIK-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
46931248
ChEBI ID
CHEMBL3644467
TTD ID
D01KKC
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasma retinol-binding protein (RBP4) TT0C8BY RET4_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215.